Related Experiment Video
Updated: May 2, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Gene expression analysis in RA: towards personalized medicine
A N Burska1, K Roget2, M Blits3
1Leeds Institute of Rheumatic and Musculoskeletal Medicine and Leeds Musculoskeletal Biomediacal Research Unit, The University of Leeds, Leeds, UK.
Abstract:
Gene expression has recently been at the forefront of advance in personalized medicine, notably in the field of cancer and transplantation, providing a rational for a similar approach in rheumatoid arthritis (RA). RA is a prototypic inflammatory autoimmune disease with a poorly understood etiopathogenesis. Inflammation is the main feature of RA; however, many biological processes are involved at different stages of the disease. Gene expression signatures offer management tools to meet the current needs for personalization of RA patients' care. This review analyses currently available information with respect to RA diagnostic, prognostic and prediction of response to therapy with a view to highlight the abundance of data, whose comparison is often inconclusive due to the mixed use of material source, experimental methodologies and analysis tools, reinforcing the need for harmonization if gene expression signatures are to become a useful clinical tool in personalized medicine for RA patients.
Insights
Gene expression signatures show promise for personalizing rheumatoid arthritis (RA) care. Harmonizing data is crucial for using these signatures effectively in clinical settings for RA patients.
Area of Science:
- Rheumatology
- Genomics
- Personalized Medicine
Background:
- Rheumatoid arthritis (RA) is a complex autoimmune disease with an unclear cause.
- Gene expression analysis is emerging as a key tool in personalized medicine.
- Current RA management requires more tailored approaches.
Purpose of the Study:
- To review the current state of gene expression signatures in rheumatoid arthritis.
- To assess their utility in diagnosis, prognosis, and predicting treatment response.
- To identify challenges hindering clinical application.
Main Methods:
- Systematic literature review of studies on gene expression in RA.
- Analysis of data from various sources, methodologies, and analytical tools.
- Evaluation of diagnostic, prognostic, and predictive applications.
Main Results:
- Gene expression signatures offer potential for personalized RA patient care.
- Significant data exists, but comparisons are often inconclusive.
- Inconsistencies arise from varied material sources, experimental methods, and analysis tools.
Conclusions:
- Harmonization of gene expression data and methodologies is essential.
- Standardization is required to translate gene expression signatures into a reliable clinical tool for RA.
- Personalized medicine approaches in RA can be advanced through standardized gene expression analysis.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

